Skip to main content
. 2017 Oct 23;8(19):4057–4064. doi: 10.7150/jca.21365

Figure 1.

Figure 1

Hazard rate (HR) for tumor recurrence over time for (A) all patients and (B) after stratification of patients according to node status (positive [N+] or negative [N-]).